Myocardial Protection With Perhexiline in Left Ventricular Hypertrophy

NCT00989508 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

220

Enrollment

OTHER

Sponsor class

Conditions

Myocardial Reperfusion Injury
Cardiac Output, Low
Hypertrophy, Left Ventricular

Interventions

DRUG: Perhexiline
DRUG: Placebo marked PEXSIG

Sponsor

University Hospital Birmingham

Collaborators

[object Object]
[object Object]
[object Object]